Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Blue light to speed healing of donor-site wounds after skin grafts

Official title: Blue Light in the Treatment of Donor Site in Burn Patient: a Controlled Clinical Trial

Run by AUSL Romagna Rimini · NCT07453927 · Data updated 2026-11-12

This study will try adding blue light therapy to usual care to see if donor-site wounds heal faster and with less pain or infection in adults with intermediate-to-deep burns who need skin grafts.

More Burn trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment25 (estimated)
SponsorAUSL Romagna Rimini
Academic / other
Locations1 site (Cesena, Forlì-Cesena)
StatusRecruiting
StartedSeptember 29, 2025
Main results expectedJuly 31, 2026
Study endsSeptember 28, 2026
Registry record updatedApril 6, 2026
Trial IDNCT07453927 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (over 18) with intermediate-to-deep burns covering more than 10% TBSA who require surgical escharectomy and have at least two donor sites are the intended participants.

Probably not a fit

Patients with superficial burns or TBSA under 10%, those with photosensitivity, patients on cytostatic or immunosuppressive therapy, pregnant or breastfeeding women, or those otherwise ineligible are unlikely to be candidates or to receive benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with intermediate-to-deep burns who require split-thickness skin grafting and have at least two donor sites will receive standard care on one donor area and standard care plus blue light photobiomodulation on another, allowing within-patient comparison. Investigators will measure time to re-epithelialization, wound condition, pain scores, signs of infection, safety and tolerability, and longer-term scar quality. The intervention consists of noninvasive blue light applied in addition to routine postoperative dressings over the donor-site healing period. The trial is conducted at the burn center of Osp. Maurizio Bufalini in Cesena, Italy.

Why it matters

Potential benefit: If successful, blue light could shorten donor-site healing time, reduce pain and infection risk, and improve long-term scar appearance.

How similar studies have gone: Preclinical studies and some clinical reports indicate blue light can have antimicrobial and wound-healing effects, but controlled data specifically for donor-site healing in burn patients are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with intermediate-deep burns with Total Body Surface Area (TBSA) \> 10% requiring surgical treatment with escharectomy, presenting at least two Donor Site.
* Patients over 18 years of age;
* Patients who have signed the informed Consent Form (ICF) and understood the purpose of the study, or, if unable to give consent personally due to their condition, their legal guardian.

Exclusion Criteria:

* Intermediate-deep burns TBSA \< 10% or superficial burns;
* Patients under the age of 18;
* Patients who are participating in other clinical trials with drugs or medical devices;
* Patients with neoplasms or other conditions requiring the use of cytostatic or immunosuppressive drugs;
* Patients with conditions that induce skin photosensitivity;
* Pregnant or breastfeeding women;
* Patients or relatives who are unable to understand the purposes of the trial;

Where it's running

  • U.O. Centro Grandi Ustionati - Osp. Maurizio Bufalini
    Cesena, Forlì-Cesena, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.